BRAIN, 2025 · DOI: 10.1093/brain/awae275 · Published: August 21, 2024
Chronic pain involves changes in spinal nociceptive circuits. The mechanistic target of rapamycin complex 2 (mTORC2) modulates structural changes and mRNA translation. Activation of spinal mTORC2 induces pain hypersensitivity. Inhibiting it, using Rictor downregulation, alleviates inflammatory and neuropathic pain. Inhibiting mTORC2 in specific excitatory neurons impairs spinal synaptic potentiation. This alleviates inflammation-induced mechanical and thermal hypersensitivity and nerve injury-induced heat hyperalgesia.
Spinal mTORC2 is a potential therapeutic target for chronic pain.
Targeting mTORC2 should consider the specific cell types involved in different pain conditions.
Antisense oligonucleotides (ASOs) targeting mTORC2 could be an efficacious therapeutic strategy.